Cardiovascular manifestations in patients with COPD;Les manifestations cardiovasculaires chez les patients atteints d'une BPCO

Revue des Maladies Respiratoires

Volumn 25, Issue 6, 2008, Pages 663-673

  Marquis, K ^a   Maltais, F ^a   Poirier, P ^a  

^a LAVAL UNIVERSITY   (Canada)

Author keywords

Arrhythmias; Arterial hypertension; Cardiovascular disease; Chronic obstructive pulmonary disease; Coronary heart disease

Indexed keywords

AMINOPHYLLINE; ANGIOTENSIN RECEPTOR ANTAGONIST; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; BRONCHODILATING AGENT; CHOLINERGIC RECEPTOR BLOCKING AGENT; DIGITALIN; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FORMOTEROL FUMARATE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; ISOPRENALINE; OXEZE; SALBUTAMOL; SALMETEROL XINAFOATE; TERBUTALINE; THEOPHYLLINE; TIOTROPIUM BROMIDE; UNCLASSIFIED DRUG; XANTHINE DERIVATIVE; ANTIARRHYTHMIC AGENT;

BRONCHUS OBSTRUCTION; CARDIOVASCULAR DISEASE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CORONARY ARTERY ATHEROSCLEROSIS; DISORDERS OF ACID BASE BALANCE; ECG ABNORMALITY; ELECTROCARDIOGRAM; EXERCISE; HEART ARRHYTHMIA; HEART FAILURE; HEART RIGHT VENTRICLE FAILURE; HUMAN; HYPERTENSION; HYPOXEMIA; LUNG DISEASE; PULMONARY HYPERTENSION; REVIEW; SUPRAVENTRICULAR PREMATURE BEAT; SUPRAVENTRICULAR TACHYCARDIA; AGED; ANOXIA; CEREBROVASCULAR DISEASE; COMPARATIVE STUDY; COR PULMONALE; CORONARY ARTERY DISEASE; ELECTROCARDIOGRAPHY; FEMALE; INCIDENCE; LIFESTYLE; LUNG FUNCTION TEST; MALE; MIDDLE AGED; PREVALENCE; RANDOMIZED CONTROLLED TRIAL; RISK FACTOR; SMOKING;

ACID-BASE IMBALANCE; AGED; ANOXIA; ANTI-ARRHYTHMIA AGENTS; ARRHYTHMIAS, CARDIAC; CARDIOVASCULAR DISEASES; CEREBROVASCULAR DISORDERS; CORONARY DISEASE; ELECTROCARDIOGRAPHY; FEMALE; HEART FAILURE; HUMANS; HYPERTENSION; INCIDENCE; LIFE STYLE; MALE; MIDDLE AGED; PREVALENCE; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; PULMONARY HEART DISEASE; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RESPIRATORY FUNCTION TESTS; RISK FACTORS; SMOKING;

EID: 55249084640     PISSN: 07618425     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0761-8425(08)73796-3     Document Type: Review

References (78)

1. Celli BR, MacNee W : Standards for the diagnosis and treatment of patients with COPD : a summary of the ATS/ERS position paper. Eur Respir J 2004 ; 23 : 932-46.
2. Agusti AG, Noguera A, Sauleda J, Sala E, Pons J, Busquets X : Systemic effects of chronic obstructive pulmonary disease. Eur Respir J 2003 ; 21 : 347-60.
3. Gan WQ, Man SF, Senthilselvan A, Sin DD : Association between chronic obstructive pulmonary disease and systemic inflammation : a systematic review and a meta-analysis. Thorax 2004 ; 59 : 574-80.
4. Huiart L, Ernst P, Suissa S : Cardiovascular morbidity and mortality in COPD. Chest 2005 ; 128 : 2640-6.
5. Sin DD, Man SF : Why are patients with chronic obstructive pulmonary disease at increased risk of cardiovascular diseases ? The potential role of systemic inflammation in chronic obstructive pulmonary disease. Circulation 2003 ; 107 : 1514-9.
6. Hansell AL, Walk JA, Soriano JB : What do chronic obstructive pulmonary disease patients die from ? A multiple cause coding analysis. Eur Respir J 2003 ; 22 : 809-14.
7. Fabbri LM, Rabe KF : From COPD to chronic systemic inflammatory syndrome ? Lancet 2007 ; 370 : 797-9.
8. Corazza LJ, Pastor BH : Cardiac arrhythmias in chronic cor pulmonale. N Engl J Med 1958 ; 259 : 862-5.
9. Holford FD, Mithoefer JC : Cardiac arrhythmias in hospitalized patients with chronic obstructive pulmonary disease. Am Rev Respir Dis 1973 ; 108 : 879-85.
10. Kleiger RE, Senior RM : Longterm electrocardiographic monitoring of ambulatory patients with chronic airway obstruction. Chest 1974 ; 65 : 483-7.
11. Montenegro HD, Chester EH, Jones PK : Cardiac arrhythmias during routine tests of pulmonary function in patients with chronic obstruction of airways. Chest 1978 ; 73 : 133-9.
12. Patel AK, Skatrud JB, Thomsen JH : Cardiac arrhythmias due to oral aminophylline in patients with chronic obstructive pulmonary disease. Chest 1981 ; 80 : 661-5.
13. Flick MR, Block AJ : Nocturnal vs diurnal cardiac arrhythmias in patients with chronic obstructive pulmonary disease. Chest 1979 ; 75 : 8-11.
14. Eidelman DH, Sami MH, McGregor M, Cosio MG : Combination of theophylline and salbutamol for arrhythmias in severe COPD. Chest 1987 ; 91 : 808-12.
15. Górecka D : Cardiac arrhythmias in chronic obstructive pulmonary disease. Monaldi Arch Chest Dis 1997 ; 52 : 278-81.
16. Cazzola M, Imperatore F, Salzillo A, Di Perna F, Calderaro F, Imperatore A, Matera MG : Cardiac effects of formoterol and salmeterol in patients suffering from COPD with preexisting cardiac arrhythmias and hypoxemia. Chest 1998 ; 114 : 411-5.
17. Biggs FD, Lefrak SS, Kleiger RE, Senior RM, Oliver GC : Disturbances of rhythm in chronic lung disease. Heart Lung 1977 ; 6 : 256-61.
18. Gulsvik A, Hansteen V, Sivertssen E : Cardiac arrhythmias in patients with serious pulmonary diseases. Scand J Respir Dis 1978 ; 59 : 154-9.
19. Sideris DA, Katsadoros DP, Valianos G, Assioura A : Type of cardiac dysrhythmias in respiratory failure. Am Heart J 1975 ; 89 : 32-5.
20. Dutt AK, de Soyza ND, Au WY, Hargis JL, Tuck RL : The effect of aminophylline on cardiac rhythm in advanced chronic obstructive pulmonary disease : correlation with serum theophylline levels. Eur J Respir Dis 1983 ; 64 : 264-70.
21. Bigger JT, Jr : Troubles du rythme cardiaque. In : Bennett JC, Plum F. Cecil Traité de médecine interne. Médecine-Sciences Flammarion, Paris 1997 : 231-53.
22. Phillips J, Spano J, Burch G : Chaotic atrial mechanism. Am Heart J 1969 ; 78 : 171-9.
23. Shine KI, Kastor JA, Yurchak PM : Multifocal atrial tachycardia. Clinical and electrocardiographic features in 32 patients. N Engl J Med 1968 ; 279 : 344-9.
24. Skwarski K : Nocturnal hypoxemia and arrhythmia in patients with chronic obstructive lung diseases (COLD). Pol Arch Med Wewn 1989 ; 81 : 283-94.
25. Schactman M, Greene J : Rhythm disturbances in the patient with pulmonary disease. Crit Care Nurse 1993 ; 13 : 40-6.
26. Rogers RM, Spear JF, Moore EN, Horowitz LH, Sonne JE : Vulnerability of canine ventricle to fibrillation during hypoxia and respiratory acidosis. Chest 1973 ; 63 : 986-94.
27. Conradson TB, Eklundh G, Olofsson B, Pahlm O, Persson G : Cardiac arrhythmias in patients with mild-to-moderate obstructive lung disease. Comparison of beta-agonist therapy alone and in combination with a xanthine derivative, enprofylline or theophylline. Chest 1985 ; 88 : 537-42.
28. Kachel RG : Coronary arterial disease and arrhythmias in chronic obstructive pulmonary disease. Chest 1979 ; 76 : 242.
29. Astin TW : Irregularities of the cardiac rhythm in cor pulmonale. Scand J Respir Dis 1973 ; 54 : 16-22.
30. Delamare J : Dictionnaire des termes de médecine. Maloine, Paris, 2000.
31. Flick MR, Block AJ : Continuous in-vivo monitoring of arterial oxygenation in chronic obstructive lung disease. Ann Intern Med 1977 ; 86 : 725-30.
32. Decker MJ, Arnold JL, Haney D, Masny J, Strohl KP : Extended monitoring of oxygen saturation in chronic lung disease. Chest 1992 ; 102 : 1075-9.
33. Tirlapur VG, Mir MA : Nocturnal hypoxemia and associated electrocardiographic changes in patients with chronic obstructive airways disease. N Engl J Med 1982 ; 306 : 125-30.
34. Assael R, Martt JM, Okeson GC : Frequency of isoproterenol hydrochloride-induced cardiac arrhythmia in 19 patients with chronic obstructive pulmonary disease : a prospective study. Am Rev Respir Dis 1975 ; 111 : 743-7.
35. Seider N, Abinader EG, Oliven A : Cardiac arrhythmias after inhaled bronchodilators in patients with COPD and ischemic heart disease. Chest 1993 ; 104 : 1070-4.
36. Lin RY, Smith AJ, Hergenroeder P : High serum albuterol levels and tachycardia in adult asthmatics treated with high-dose continuously aerosolized albuterol. Chest 1993 ; 103 : 221-5.
37. Salpeter SR : Cardiovascular safety of beta(2)-adrenoceptor agonist use in patients with obstructive airway disease : a systematic review. Drugs Aging 2004 ; 21 : 405-14.
38. Poukkula A, Korhonen UR, Huikuri H, Linnaluoto M : Theophylline and salbutamol in combination in patients with obstructive pulmonary disease and concurrent heart disease : effect on cardiac arrhythmias. J Intern Med 1989 ; 226 : 229-34.
39. Mountain RD, Neff TA : Oral theophylline intoxication. A serious error of patient and physician understanding. Arch Intern Med 1984 ; 144 : 724-7.
40. Kirby BJ, McNicol MW, Tattersfield AE : Arrhythmias, digitalis and respiratory failure. Br J Dis Chest 1970 ; 64 : 212-9.
41. Beller GA, Smith TW, Abelmann WH, Haber E, Hood WB, Jr : Digitalis intoxication. A prospective clinical study with serum level correlations. N Engl J Med 1971 ; 284 : 989-97.
42. Klein MD, Lown B, Barr I, Hagemeijer F, Garrison H, Axelrod P : Comparison of serum digoxin level measurement with acetyl strophanthidin tolerance testing. Circulation 1974 ; 49 : 1053-62.
43. Morrison J, Killip T : Hypoxemia and digitalis toxicity in patients with chronic lung disease. Circulation 1971 ; 44 : Sii-41.
44. Shih HT, Webb CR, Conway WA, Peterson E, Tilley B, Goldstein S : Frequency and significance of cardiac arrhythmias in chronic obstructive lung disease. Chest 1988 ; 94 : 44-8.
45. Bittar G, Friedman HS : The arrhythmogenicity of theophylline. A multivariate analysis of clinical determinants. Chest 1991 ; 99 : 1415-20.
46. Morganroth J, Golisch W, Kesten S : Eletrocardiographic monitoring in COPD patients receiving tiotropium. COPD 2004 ; 1 : 181-90.
47. Covelli H, Bhattacharya S, Cassino C, Conoscenti C, Kesten S : Absence of electrocardiographic findings and improved function with once-daily tiotropium in patients with chronic obstructive pulmonary disease. Pharmacotherapy 2005 ; 25 : 1708-18.
48. Murphy ML, Adamson J, Hutcheson F : Left ventricular hypertrophy in patients with chronic bronchitis and emphysema. Ann Intern Med 1974 ; 81 : 307-13.
49. Senior RM, Lefrak SS, Kleiger RE : Coronary arterial disease and arrhythmias in chronic obstructive pulmonary disease. Chest 1979 ; 76 : 242.
50. Nici L, Donner C, Wouters E, Zuwallack R, Ambrosino N, Bourbeau J, Carone M, Celli B, Engelen M, Fahy B, Garvey C, Goldstein R, Gosselink R, Lareau S, MacIntyre N, Maltais F, Morgan M, O'Donnell D, Prefault C, Reardon J, Rochester C, Schols A, Singh S, Troosters T : American Thoracic Society/European Respiratory Society statement on pulmonary rehabilitation. Am J Respir Crit Care Med 2006 ; 173 : 1390-413.
51. Maltais F, Bourbeau J, Lacasse Y, Shapiro S, Perrault H, Penrod JR, Baltzan M, Rouleau M, Julien M, Paradis B, Audet R, Hernandez P, Levy RD, Camp P, Lecours R, Picard D, Bernard S : A Canadian, multicentre, randomized clinical trial of home-based pulmonary rehabilitation in chronic obstructive pulmonary disease : rationale and methods. Can Respir J 2005 ; 12 : 193-8.
52. Cheong TH, Magder S, Shapiro S, Martin JG, Levy RD : Cardiac arrhythmias during exercise in severe chronic obstructive pulmonary disease. Chest 1990 ; 97 : 793-7.
53. Kuzman WJ, Ajac IK : Emphysema and hypertension. J Asthma Res 1966 ; 4 : 7-12.
54. Anderson AE, Jr., Bedrossian CW, Foraker AG : Systemic blood pressure in subjects with and without emphysema. Am Rev Respir Dis 1971 ; 103 : 576-8.
55. Kassis E : Systemic hypertension, left ventricular hypertrophy and myocardial infarction in patients with chronic obstructive lung disease. Scand J Respir Dis 1977 ; 58 : 324-9.
56. Fontana F, Bernardi P, Tartuferi L, Boschi S, De Iasio R, Merlo PE : Mechanisms of hypertension in patients with chronic obstructive pulmonary disease and acute respiratory failure. Am J Med 2000 ; 109 : 621-7.
57. McGarvey LP, John M, Anderson JA, Zvarich M, Wise RA : Ascertainment of cause-specific mortality in COPD : operations of the TORCH Clinical Endpoint Committee. Thorax 2007 ; 62 : 411-5.
58. Thomas AJ : Coronary heart disease in the presence of pulmonary disease. Br Heart J 1958 ; 20 : 83-91.
59. Karpick RJ, Pratt PC, Asmundsson T, Kilburn KH : Pathological findings in respiratory failure. Goblet cell metaplasia, alveolar damage, and myocardial infarction. Ann Intern Med 1970 ; 72 : 189-97.
60. Thurnheer R, Muntwyler J, Stammberger U, Bloch KE, Zollinger A, Weder W, Russi EW : Coronary artery disease in patients undergoing lung volume reduction surgery for emphysema. Chest 1997 ; 112 : 122-8.
61. Schunemann HJ, Dorn J, Grant BJ, Winkelstein W, Jr, Trevisan M : Pulmonary function is a long-term predictor of mortality in the general population : 29-year follow-up of the Buffalo Health Study. Chest 2000 ; 118 : 656-64.
62. Bang KM, Gergen PJ, Kramer R, Cohen B : The effect of pulmonary impairment on all-cause mortality in a national cohort. Chest 1993 ; 103 : 536-40.
63. Hole DJ, Watt GC, Davey-Smith G, Hart CL, Gillis CR, Hawthorne VM : Impaired lung function and mortality risk in men and women : findings from the Renfrew and Paisley prospective population study. BMJ 1996 ; 313 : 711-5.
64. Engstrom G, Lind P, Hedblad B, Wollmer P, Stavenow L, Janzon L, Lindgarde F : Lung function and cardiovascular risk : relationship with inflammation-sensitive plasma proteins. Circulation 2002 ; 106 : 2555-60.
65. Danesh J, Whincup P, Walker M, Lennon L, Thomson A, Appleby P, Gallimore JR, Pepys MB : Low grade inflammation and coronary heart disease : prospective study and updated meta-analyses. BMJ 2000 ; 321 : 199-204.
66. Ridker PM : Evaluating novel cardiovascular risk factors : can we better predict heart attacks ? Ann Intern Med 1999 ; 130 : 933-7.
67. Yanbaeva DG, Dentener MA, Creutzberg EC, Wesseling G, Wouters EF : Systemic effects of smoking. Chest 2007 ; 131 : 1557-66.
68. Soyseth V, Brekke PH, Smith P, Omland T : Statin use is associated with reduced mortality in COPD. Eur Respir J 2007 ; 29 : 279-83.
69. Marquis K, Maltais F, Duguay V, Bezeau AM, LeBlanc P, Jobin J, Poirier P : The metabolic syndrome in patients with chronic obstructive pulmonary disease. J cardiopulm rehabil 2005 ; 25 : 226-32.
70. Curkendall SM, DeLuise C, Jones JK, Lanes S, Stang MR, Goehring E Jr, She D : Cardiovascular disease in patients with chronic obstructive pulmonary disease, Saskatchewan Canada cardiovascular disease in COPD patients. Ann Epidemiol 2006 ; 16 : 63-70.
71. Sidney S, Sorel M, Quesenberry CP, Jr, DeLuise C, Lanes S, Eisner MD : COPD and incident cardiovascular disease hospitalizations and mortality : Kaiser Permanente Medical Care Program. Chest 2005 ; 128 : 2068-75.
72. Rutten FH, Cramer MJ, Grobbee DE, Sachs AP, Kirkels JH, Lammers JW, Hoes AW : Unrecognized heart failure in elderly patients with stable chronic obstructive pulmonary disease. Eur Heart J 2005 ; 26 : 1887-94.
73. Rutten FH, Moons KG, Cramer MJ, Grobbee DE, Zuithoff NP, Lammers JW, Hoes AW : Recognising heart failure in elderly patients with stable chronic obstructive pulmonary disease in primary care : cross sectional diagnostic study. BMJ 2005 ; 331 : 1379.
74. Lang CC, Coutie WJ, Struthers AD, Dhillon DP, Winter JH, Lipworth BJ : Elevated levels of brain natriuretic peptide in acute hypoxaemic chronic obstructive pulmonary disease. Clin Sci (Lond) 1992 ; 83 : 529-33.
75. Troughton RW, Prior DL, Pereira JJ, Martin M, Fogarty A, Morehead A, Yandle TG, Richards AM, Starling RC, Young JB, Thomas JD, Klein AL : Plasma B-type natriuretic peptide levels in systolic heart failure : importance of left ventricular diastolic function and right ventricular systolic function. J Am Coll Cardiol 2004 ; 43 : 416-22.
76. Render ML, Weinstein AS, Blaustein AS : Left ventricular dysfunction in deteriorating patients with chronic obstructive pulmonary disease. Chest 1995 ; 107 : 162-8.
77. Blair SN, Kampert JB, Kohl HW, III, Barlow CE, Macera CA, Paffenbarger RS, Jr , Gibbons LW : Influences of cardiorespiratory fitness and other precursors on cardiovascular disease and all-cause mortality in men and women. JAMA 1996 ; 276 : 205-10.
78. Mancini GB, Etminan M, Zhang B, Levesque LE, FitzGerald JM, Brophy JM : Reduction of morbidity and mortality by statins, angiotensin-converting enzyme inhibitors, and angiotensin receptor blockers in patients with chronic obstructive pulmonary disease. J Am Coll Cardiol 2006 ; 47 : 2554-60.